Ticker brief
IBB ISHARES BIOTECHNOLOGY ETF
last close
$207.74
1 day
-0.9%
14 days
+0.6%
mkt cap
·
signals 14d
33
authors 14d
18
crowd 14d
-1.6σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 26% rich · 95 pctile own 1y | IV/HV 1.18× |
| Skew — 25Δ RR 30d | +0.008 96 pctile own 1y | calls bid vs puts (call skew rich) |
| OI alarm | quiet | last alarm 2025-05-12 (z=2.5) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-03 → 2026-10-14 · now +0.40 (−1 bearish … +1 bullish)
Who spoke18
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @kulturdesken | B | +0.49 | 5 | +0.29 |
| @BiopharmIQ | B | · | 4 | +0.06 |
| @kpak82 | C | -1.13 | 3 | -0.59 |
| @RevShark | B | +1.92 | 3 | -0.23 |
| @kkernttb | C | -0.95 | 2 | +0.12 |
| @evanmedeiros | B | -0.95 | 2 | -0.50 |
| @VistaPResearch | C | · | 2 | +0.30 |
| @TheETFTracker | C | +0.19 | 2 | +0.00 |
| @KeithMcCullough | A | -3.03 | 1 | +0.65 |
| @Paul_Schatz | C | +1.08 | 1 | +0.70 |
| @eugeniodeveze | C | -3.14 | 1 | +0.35 |
| @DrStoxx | C | +0.18 | 1 | -0.25 |
| @EquityClock | A | -0.07 | 1 | -0.60 |
| @tradertvshawn | C | -0.52 | 1 | +0.40 |
| @RESERVAdeVALOR | C | -1.11 | 1 | +0.00 |
| @VolumeLeaders | A | +0.57 | 1 | +0.00 |
| @HedgeFundTips | B | +0.73 | 1 | +0.00 |
| @cfromhertz | B | -0.96 | 1 | +0.40 |
Recent signals30of 33 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-14 | @cfromhertz | +0.40 | Health-care ETFs show relative strength with gains between 1.1% and 1.7%. | +2.2% | tweet ↗ |
| 2026-10-13 | @TheETFTracker | -0.40 | Recaps daily ETF performance, led by energy gains and biotechnology losses. | +3.9% | tweet ↗ |
| 2026-10-13 | @HedgeFundTips | +0.00 | Shares a chart covering biotech earnings estimates and revisions. | +3.9% | tweet ↗ |
| 2026-10-11 | @kkernttb | +0.00 | Ticker-only post appears to reference an unseen chart. | +0.6% | tweet ↗ |
| 2026-10-10 | @kulturdesken | +0.40 | Weekly framework maps bullish structure, macro risks, sector rotation and Monday focus names. | +0.6% | tweet ↗ |
| 2026-10-09 | @BiopharmIQ | +0.15 | Compares weekly and year-to-date returns for three biotech ETFs. | +0.6% | tweet ↗ |
| 2026-10-09 | @BiopharmIQ | +0.15 | Lists exact weekly prices and returns plus year-to-date performance for three biotech ETFs. | +0.6% | tweet ↗ |
| 2026-10-09 | @TheETFTracker | +0.40 | Reports daily ETF performance led by precious metals and biotechnology. | +0.6% | tweet ↗ |
| 2026-10-09 | @kulturdesken | +0.30 | Discloses expanded macro holdings and a re-entry into SMH after an earlier cut. | +0.6% | tweet ↗ |
| 2026-10-08 | @VolumeLeaders | +0.00 | Reports IBB's largest trade since May 2020 and lists its principal holdings. | +3.6% | tweet ↗ |
| 2026-10-08 | @VistaPResearch | +0.35 | Treats a $2.6B biotech raise as evidence of renewed smart-money backing. | +3.6% | tweet ↗ |
| 2026-10-08 | @VistaPResearch | +0.25 | Suggests Parkinson's research developments deserve investor attention. | +3.6% | tweet ↗ |
| 2026-10-08 | @kulturdesken | +0.65 | Discloses purchases of IBB and XLF and an addition of IWM based on yield moves. | +3.6% | tweet ↗ |
| 2026-10-08 | @kulturdesken | +0.00 | Notes IBB is at a technical level while explicitly disclosing no position. | +3.6% | tweet ↗ |
| 2026-10-08 | @evanmedeiros | -0.50 | Biotech ETFs are breaking nearby technical support during a weak week | +3.6% | tweet ↗ |
| 2026-10-08 | @kulturdesken | +0.10 | Locates IBB at the lower portion of its chart channel. | +3.6% | tweet ↗ |
| 2026-10-08 | @kpak82 | -0.50 | Reports IBB breaking below a two-month range. | +3.6% | tweet ↗ |
| 2026-10-08 | @RevShark | -0.60 | Biotechnology ETFs are expected to face further selling as investors continue reducing exposure. | +3.6% | tweet ↗ |
| 2026-10-07 | @RESERVAdeVALOR | +0.00 | Shares an updated weekly IBB biotechnology ETF chart without a stated direction. | +2.2% | tweet ↗ |
| 2026-10-07 | @tradertvshawn | +0.40 | Explicitly endorses an IBB idea, though the underlying thesis is absent. | +2.2% | tweet ↗ |
| 2026-10-06 | @EquityClock | -0.60 | Bearish engulfing pattern and ended seasonality imply biotech upside exhaustion. | +2.3% | tweet ↗ |
| 2026-10-06 | @evanmedeiros | -0.50 | Bearish engulfing pattern and heavier volume threaten biotech support near 200. | +2.3% | tweet ↗ |
| 2026-10-06 | @DrStoxx | -0.25 | Reports genomics assets were hit after plague-related news was deemed false. | +2.3% | tweet ↗ |
| 2026-10-06 | @RevShark | +0.40 | Reports a large biotech rebound attributed to ETF-driven volatility. | +2.3% | tweet ↗ |
| 2026-10-06 | @eugeniodeveze | +0.35 | Broad market briefing links oil, yields, Fed expectations, macro data and sector performance. | +2.3% | tweet ↗ |
| 2026-10-06 | @RevShark | -0.50 | Reports widespread biotech breakdowns across IBB and several constituent names. | +2.3% | tweet ↗ |
| 2026-10-05 | @Paul_Schatz | +0.70 | Discloses purchases in six named assets; additional sales are omitted due to the six-ticker cap. | -0.1% | tweet ↗ |
| 2026-10-05 | @KeithMcCullough | +0.65 | Praises a completed Friday dip purchase in biotech ETF IBB. | -0.1% | tweet ↗ |
| 2026-10-04 | @kpak82 | -0.62 | Sees an initial monthly bearish reversal at all-time highs and channel resistance. | +1.2% | tweet ↗ |
| 2026-10-04 | @kpak82 | -0.65 | Notes IBB is below short-term averages and could enter a sustained downtrend. | +1.2% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.